SATCO CAPITAL MARKETS LTD.("WINDOW TO THE WORLD OF INVESTMENT OPPORTUNITIES")

BLOGS
GO
BUDGET 2018-19
WHAT'S NEW
googlemarker
Open An Account
Secure With Us
Trade on Mobile

MARKETS & OUR SERVICES

Equity

CIPLA LTD.

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & Drugs MCap (Rs. in Mn) : 410648.73 Face Value (Rs.) : 2 House : Cipla
BSE509.70-0.05 (-0.01 %)
PREV CLOSE (Rs.) 509.75
OPEN PRICE (Rs.) 512.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 115493
TODAY'S LOW / HIGH (Rs.)507.50 512.90
52 WK LOW / HIGH (Rs.)503.95 678
NSE509.40-0.2 (-0.04 %)
PREV CLOSE( Rs. ) 509.60
OPEN PRICE (Rs.) 510.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 509.40 (560)
VOLUME 1502360
TODAY'S LOW / HIGH(Rs.) 507.30 513.00
52 WK LOW / HIGH (Rs.)503 678.45
Home Markets & Our ServicesCompany ProfileSmart Quotes
BSE NSE
1D 1M 3M 1Y 3Y 5Y
Trade Value (Rs. in Lacs)
588.94
Dividend Yield(%)
0.59
TTM EPS (Rs.)
19.89
P/E Ratio
25.63
Book Value (Rs.)
183.33
Face Value (Rs.)
2
MCap (Rs. in Mn)
410648.73
Price/Earning (TTM)
19.10
Price/Sales (TTM)
3.61
Price/Book (MRQ)
2.78
PAT Margin (%)
12.83
ROCE (%)
14.03
Incorporation Year : 17-08 1935

Management Info :

Y K Hamied - Chairman Umang Vohra - Managing Director

Registered Office :

Address : Cipla House,Peninsula Business Park,Ganpatrao Kadam Marg, Lower Parel,
Mumbai,
Maharashtra-400013

Phone : 022-24826000 / 022-24826951

Website : www.cipla.com

Registrars Details :

Karvy Fintech Pvt Ltd.-(Karvy Computuershare Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, Luxembourg, MCX
07Jan Loss of Share Certificate / Issue of
Cipla Ltd has informed BSE regarding Loss of Share Certificate / Issue o..
31Dec Cipla recalling 4,800 bottles of Nevir
Cipla is recalling 4,800 bottles of Nevirapine extended release tablets..
31Dec Cipla informs about schedule of analys
Cipla has informed about submission of the letter dated 31st December, 2..
more
QTR Sep 18 ANNUAL 18
Net Profit5684.714685.2
Gross Profit 7234.3 19114
Operating Profit 8721.7 25304.3
Net Sales 30947.1 114448.1
more
Rs. in Millions
Alkem Laboratories (BSE)
img  1902.30 (0.69%)
M.Cap (Rs. in Cr)22744.85
Neuland Laboratories (BSE)
img  514.45 (2.53%)
M.Cap (Rs. in Cr)660.03
Merck (BSE)
img  3188.80 (0.37%)
M.Cap (Rs. in Cr)5293.21
Hester Biosciences (BSE)
img  1150.60 (0.93%)
M.Cap (Rs. in Cr)978.80
PROMOTERS
36.7%
NON-INSTITUTION
23.69%
MUTUAL FUNDS/UTI
10.9%
FI/BANKS/INSURANCE
2.83%
FII
0.61%
GOVERNMENT
0%
more
site map
Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.....Issued in the interest of investors.  |  No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. |  KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
Dear Client, Pursuant to SEBI regulation, update your KYC details through KRA form with supporting documents at earliest to complete KYC-KRA requirement. If already submitted, kindly ignore. For any information, in this regard, please contact to our KYC Department on 022-66556772/73/74 or email at kyc@satco.co.in.
  • NSE - INZ000198838  | 
  • BSE- INZ000198838  | 
  • MCX- INZ000198838  | 
  • NCDEX- INZ000198838  | 
  • CDSL – IN-DP-CDSL-727-2014  | 
  • PMS - INP000003492  | 
  • RESEARCH – INH000002343
  • © Copyright 2015. SATCO CAPITAL MARKETS LTD. || Designed Developed & Content Powered By ●●●Accord Fintech Pvt.Ltd.
VISIT COUNT     1296210